<h2></h2>

Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block 23andMe from selling personal genetic data without customer consent as the company undergoes Chapter 11 bankruptcy proceedings.

Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block 23andMe from selling personal genetic data without customer consent as the company undergoes Chapter 11 bankruptcy proceedings.

Regeneron Pharmaceuticals in <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.improvethenews.org/story/2025/regeneron-acquires-andme-for-m-amid-privacy-concerns">May announced plans to acquire 23andMe for $256 million</a>, with the deal requiring court approval and facing scrutiny from a court-appointed consumer privacy ombudsman, who must report findings by Tuesday.

Regeneron Pharmaceuticals in May announced plans to acquire 23andMe for $256 million, with the deal requiring court approval and facing scrutiny from a court-appointed consumer privacy ombudsman, who must report findings by Tuesday.

The lawsuit argues that biological samples, DNA data, health-related traits, and medical records are too sensitive to be sold without each person's express, informed consent, with Oregon Attorney General Dan Rayfield saying in a statement that the data "cannot be sold like ordinary property."

The lawsuit argues that biological samples, DNA data, health-related traits, and medical records are too sensitive to be sold without each person's express, informed consent, with Oregon Attorney General Dan Rayfield saying in a statement that the data "cannot be sold like ordinary property."

23andMe <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.improvethenews.org/story/2025/andme-files-bankruptcy-as-ceo-exits-amid-takeover-drama">filed for Chapter 11 bankruptcy protection in March</a> after struggling financially since going public in 2021, laying off 40% of its staff and raising concerns about the safety of customer data from more than 15 million users.

23andMe filed for Chapter 11 bankruptcy protection in March after struggling financially since going public in 2021, laying off 40% of its staff and raising concerns about the safety of customer data from more than 15 million users.

The company previously suffered a data breach in 2023 that affected nearly 7 million customers. Hackers leaked personal data, including origin estimation, phenotype, health information, photos, and identification data on online forums.

The company previously suffered a data breach in 2023 that affected nearly 7 million customers. Hackers leaked personal data, including origin estimation, phenotype, health information, photos, and identification data on online forums.

States Sue to Block 23andMe DNA Data Sale Without Consent

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

States Sue to Block 23andMe DNA Data Sale Without Consent

Sign Up for Our Free NewslettersSign Up for Our Free Newsletters

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters